Clinical evaluation of the efficacy and safety of Luxiva brand skin mesotherapy solution for rejuvenation of facial ski
- Conditions
- Skin hydration.
- Registration Number
- IRCT20150101020514N25
- Lead Sponsor
- Atra Zist Arai Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Age between 35 and 60 years old
Present visible signs of skin ageing symptoms mainly skin dryness skin roughness, loss of elasticity and appearance of fine lines
Possibility to accompany the visit plans and study process.
Signing an informed consent form and agreed to follow up.
Previous treatment with hyaluronic acid fillers in the facial area within the past year
Experience with RF, rejuvenation lasers or intense pulsed light in the past 6 months
Systemic diseases affecting skin health such as collagen vascular diseases, diabetes, hypothyroidism, as well as liver and renal failure.
History of systemic use of skin-related medicine such as glucocorticoids, isotretinoin, immunomodulators and hormonal medicine in the past 3 months
Currently pregnant or lactating
Smoking in the past two years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin elasticity. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Cutometery.
- Secondary Outcome Measures
Name Time Method Stratum corneum hydration. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Corneometry by MPA 580.;Skin condition for signs of skin aging including clear lines and wrinkles. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Using GAIS scale.